Regenerative Medical Technology (RMTG) Share-based Compensation Growth (5y) (2024)
Powered by 
Analysis
Regenerative Medical Technology (RMTG) Share-based Compensation Growth (5y) (2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.55 Bn | 2.59 Bn | 251.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.17 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.95 Bn | 1.78 Bn | 56.40 Mn |
| 10 | Regenerative Medical Technology | 1.18 Mn | -139,694.93 | 2.58 Mn |